Atlas FDA

RADIESSE INJECTABLE IMPLANT

FDA premarket approval P050037/S026 · decided 2012-03-14

Approval details

PMA number
P050037
Supplement
S026
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
RADIESSE INJECTABLE IMPLANT
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2011-01-11
Decision date
2012-03-14
Days to decision
428 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
APPROVAL FOR A MANUFACTURING SITE LOCATED IN STURTEVANT, WISCONSIN.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29